Cemiplimab, a human PD-1 monoclonal antibody, in patients (pts) with recurrent or metastatic cervical cancer: Interim data from phase I cohorts

Autores: Rischin, D.; Gil-Martin, M.; González Martín, Antonio; Brana, I. ; Hou, J. Y.; Cho, D. ; Falchook, G. ; Formenti, S.; Jabbour, S.; Moore, K.; Naing, A. ; Papadopoulos, K. P.; Baranda, J.; Weise, A.; Fury, M. G. ; Feng, M.; Li, J.; Lowy, I.; Mathias, M.